Paragon 28/FNA

$9.88

2.38%
-
1D1W1MYTD1YMAX

About Paragon 28

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.

Ticker

FNA

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Albert Dacosta

Employees

430

Headquarters

Englewood, United States

Paragon 28 Metrics

BasicAdvanced
$806.68M
Market cap
-
P/E ratio
-$0.58
EPS
-
Beta
-
Dividend rate
$806.68M
$19.72
$7.95
519.61K
4.212
2.298
61.775
62.135
-7.22%
-16.09%
-30.03%
-20.14%
3.728
4.534
6.177
19.3%
33.46%
24.93%

What the Analysts think about Paragon 28

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 6 analysts.
82.19% upside
High $23.00
Low $15.00
$9.88
Current price
$18.00
Average price target

Paragon 28 Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-32.23% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$60.5M
14.8%
Net income
$-19.5M
134.94%
Profit margin
-32.23%
104.76%

Paragon 28 Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 152.75%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.11
-$0.13
-$0.10
-$0.23
-
Expected
-$0.10
-$0.10
-$0.10
-$0.09
-$0.12
Surprise
5.48%
26.57%
-3.96%
152.75%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Paragon 28 stock?

Paragon 28 (FNA) has a market cap of $806.68M as of April 19, 2024.

What is the P/E ratio for Paragon 28 stock?

The price to earnings (P/E) ratio for Paragon 28 (FNA) stock is 0 as of April 19, 2024.

Does Paragon 28 stock pay dividends?

No, Paragon 28 (FNA) stock does not pay dividends to its shareholders as of April 19, 2024.

When is the next Paragon 28 dividend payment date?

Paragon 28 (FNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Paragon 28?

Paragon 28 (FNA) does not currently have a Beta indicator.

What is the Paragon 28 stock price target?

The target price for Paragon 28 (FNA) stock is $18, which is 82.19% above the current price of $9.88. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Paragon 28 stock

Buy or sell Paragon 28 stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing